Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Brazil
/
Healthcare
Create a narrative
Healthcare Brazilian Community
Our community narratives are driven by numbers and valuation.
Create a narrative
All companies
Popular
Undervalued
Overvalued
Healthcare Brazilian Investing Ideas
Fleury
AN
AnalystConsensusTarget
Consensus Narrative from 11 Analysts
Integration With Pardini Group And Key Acquisitions Will Extend The Service Footprint
Key Takeaways Strategic acquisitions and expanded service offerings are driving revenue growth and enhancing operational synergies with geographic expansion and market share gains. Digitalization and mobile services are improving customer satisfaction and efficiency, potentially boosting net margins and earnings with minimal investment.
View narrative
R$14.95
FV
4.8% undervalued
intrinsic discount
6.58%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
2 days ago
author updated this narrative
Oncoclínicas do Brasil Serviços Médicos
AN
AnalystConsensusTarget
Consensus Narrative from 8 Analysts
Debt Reduction And Revenue Diversification Will Secure Future Stability
Key Takeaways Strategic partnerships and revenue diversification efforts aim to stabilize and enhance growth, reducing reliance on major clients and expanding market reach. Operational efficiency and conservative financial management are set to optimize margins, strengthen financial health, and bolster investor confidence.
View narrative
R$5.23
FV
8.1% overvalued
intrinsic discount
9.10%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
2 days ago
author updated this narrative
Odontoprev
AN
AnalystConsensusTarget
Consensus Narrative from 11 Analysts
SME Bancassurance Expansion Will Improve Future Efficiency
Key Takeaways Strategic focus on bancassurance and SME growth is likely to enhance revenue, profitability, and customer acquisition. Improved cost management and tech investments optimize operations, boosting profitability and net margins.
View narrative
R$11.90
FV
2.1% overvalued
intrinsic discount
4.44%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
2 days ago
author updated this narrative
Hapvida Participações e Investimentos
AN
AnalystConsensusTarget
Consensus Narrative from 14 Analysts
Acquisitions And BRL2 Billion Investment Will Upgrade Health Care Services
Key Takeaways Successful acquisition integrations and infrastructure investments improve service quality, operational efficiency, and capacity, enhancing revenue and net margins through expanded and improved service offerings. Stable financial position and verticalization strategy support growth through increased patient intake, higher-margin revenues, and investments in technology and facilities.
View narrative
R$59.77
FV
45.4% undervalued
intrinsic discount
8.11%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
2 days ago
author updated this narrative
Rede D'Or São Luiz
AN
AnalystConsensusTarget
Consensus Narrative from 14 Analysts
Consolidation With SulAmérica Will Reduce Execution Risk And Open Opportunities
Key Takeaways Organic expansion and new hospital systems are poised to boost operational efficiency and improve net margins. Strategic partnerships and synergies, including with SulAmérica, are opening growth opportunities and enhancing earnings.
View narrative
R$40.46
FV
19.9% undervalued
intrinsic discount
12.25%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
9
users have followed this narrative
2 days ago
author updated this narrative
Fleury
AN
AnalystLowTarget
Consensus Narrative from 11 Analysts
Brazil Telemedicine Rise Will Erode Outpatient Volumes But Foster Efficiency
Key Takeaways Surging digital health adoption and asset-light competitors threaten Fleury's traditional business model and ability to protect premium market share. Policy changes and commoditization may pressure pricing power, margins, and long-term revenue stability in Brazil's private healthcare sector.
View narrative
R$11.50
FV
23.8% overvalued
intrinsic discount
6.22%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Fleury
AN
AnalystHighTarget
Consensus Narrative from 11 Analysts
Brazil's Aging Population And Digitalization Will Boost Premium Demand
Key Takeaways Accelerated success in integration, digital adoption, and specialty care expansion is unlocking stronger margins, faster growth, and higher returns than analysts predict. Unmatched scale, premium service offerings, and rising healthcare demand position Fleury for outsized market share gains and enduring profitability.
View narrative
R$19.50
FV
27.0% undervalued
intrinsic discount
7.63%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Oncoclínicas do Brasil Serviços Médicos
AN
AnalystLowTarget
Consensus Narrative from 8 Analysts
Brazil's Tightening Policies And High Costs Will Erode Margins
Key Takeaways Regulatory intervention, inflation, and a shift toward value-based care threaten profit margins and the company's traditional revenue model. Rapid expansion and technological demands increase financial risk and could lead to structurally lower earnings amid higher market competition.
View narrative
R$2.00
FV
182.5% overvalued
intrinsic discount
8.66%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
9 days ago
author updated this narrative
Hapvida Participações e Investimentos
AN
AnalystLowTarget
Consensus Narrative from 14 Analysts
Rising Litigation And Inflation Will Undermine Brazil Healthcare
Key Takeaways Income inequality, regulatory risks, and medical inflation may restrict revenue growth and compress margins despite rising healthcare demand and digitalization efforts. Operational challenges from M&A integration and slow geographic expansion could hinder anticipated efficiencies and leave the company vulnerable to stagnating membership and revenue.
View narrative
R$45.00
FV
27.4% undervalued
intrinsic discount
7.80%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
9 days ago
author updated this narrative
Value any company in seconds
Popular companies